Question follow-through · 112057
Life Sciences
To ask the Secretary of State for Health and Social Care, what consideration has been given to the role of the generic and biosimilar medicines sector in shaping life sciences policy, in the context of it supplying around 85% of NHS prescription drugs by
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 9 Feb 2026
- Target answer date
- 11 Feb 2026
- Answer
- 17 Feb 2026 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Alcoholic Drinks: Labelling · 10 Feb 2026
- Alcoholic Drinks: Labelling · 10 Feb 2026
- Alcoholic Drinks: Labelling · 10 Feb 2026
- Alcoholic Drinks: Labelling · 10 Feb 2026
- Alcoholic Drinks: Labelling · 10 Feb 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
9 Feb 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what consideration has been given to the role of the generic and biosimilar medicines sector in shaping life sciences policy, in the context of it supplying around 85% of NHS prescription drugs by
11 Feb 2026
Target answer date
Date supplied by the official written-questions record.
17 Feb 2026
Answer published
The United Kingdom’s world leading life sciences sector is central to our Industrial Strategy, driving growth, investment, and high-quality jobs. As set out in the Life Sciences Sector Plan, which we developed while working closely with the sector, there ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Alcoholic Drinks: Labelling
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, with reference to the National Cancer Plan for England, if he will set out the formats for mandatory health warnings on alcohol labels that his Department is considering, including whether these in
Alcoholic Drinks: Labelling
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, with reference to the National Cancer Plan for England, what empirical evidence his Department is reviewing to inform the design of mandatory alcohol health warnings, including those used in South
Alcoholic Drinks: Labelling
10 Feb 2026 · To ask the Secretary of State for Health and Social Care when he plans to publish draft designs for mandatory alcohol health warnings; and what his planned timetable is for (a) consultation on and (b) the implementation of those warnings.
Alcoholic Drinks: Labelling
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, what plans his Department has to develop a definition of health warning for the purposes of alcohol labelling reforms.
Alcoholic Drinks: Labelling
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of proposed mandatory alcohol labelling reforms on producers, small businesses, supply chains and exporters.
Alcoholic Drinks: Labelling
10 Feb 2026 · To ask the Secretary of State for Health and Social Care what assessment he has made of the feasibility and cost implications of introducing rotating health warnings on alcohol products, including for long-lifecycle products such as wine.
Health Hazards: Labelling
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether his Department has assessed the potential merits of using QR codes or digital labelling to supplement mandatory on-label health warnings.
Alcoholic Drinks: Labelling
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential merits of mandatory alcohol health warnings for regulatory alignment with the EU, Ireland, and other trading partners.
Alcoholic Drinks: Labelling
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether mandatory alcohol labelling requirements will apply to both on-trade and off-trade settings.
Alcohol Drinks: Labelling
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure industry and civil society are prepared for the forthcoming consultation on mandatory alcohol labelling; and whether draft policy scenarios will be sha
Doctors: Misconduct
12 Feb 2026 · To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the EU regarding access to doctor malpractice data through the Internal Market Information system.
Pharmacy: Business Rates
12 Feb 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of extending business rates relief to community pharmacies.